Actuate Therapeutics ACTU
NASDAQ ACTU
$0.78 +0.09 (+13.04%)
At close: Sep 30, 2026 · 4:00 PM EDT

Actuate Therapeutics (ACTU) Other Non-Current Assets (2024 - 2026)

Updated

Actuate Therapeutics (ACTU) recorded Other Non-Current Assets of $451,398 in Q2 2026, up 61.0% from $280,342 a year earlier.

Analysis

Actuate Therapeutics (ACTU) Other Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Actuate Therapeutics reported Other Non-Current Assets of $392,491, up 255.0% from FY2024.

  • Across earlier years, Other Non-Current Assets came in at $110,548 in FY2024.
  • The Q2 2026 figure is the highest quarterly Other Non-Current Assets since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Actuate Therapeutics 18.73 Mn 18.73 Mn - 451,398.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 451,398.00
Dec 31, 2025 392,491.00
Sep 30, 2025 269,934.00
Jun 30, 2025 280,342.00
Mar 31, 2025 234,475.00
Dec 31, 2024 110,548.00
Jun 30, 2024 1.18 Mn
API Access

Actuate Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ACTU&period=max&api_key=YOUR_API_KEY